| Effects of cancer stage and treatment differences on racial disparities in survival from colon cancer: a United States population-based study Y Lai, C Wang, JM Civan, JP Palazzo, Z Ye, T Hyslop, J Lin, RE Myers, ... Gastroenterology 150 (5), 1135-1146, 2016 | 113 | 2016 |
| Ruxolitinib+ capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies H Hurwitz, E Van Cutsem, J Bendell, M Hidalgo, CP Li, MG Salvo, ... Investigational new drugs 36, 683-695, 2018 | 93 | 2018 |
| Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (aHCC): Long-term results from CheckMate 040. AB El-Khoueiry, T Yau, YK Kang, TY Kim, A Santoro, B Sangro, I Melero, ... Journal of Clinical Oncology 39 (3_suppl), 269-269, 2021 | 50 | 2021 |
| First‐in‐human phase I study of merestinib, an oral multikinase inhibitor, in patients with advanced cancer AR He, RB Cohen, CS Denlinger, A Sama, A Birnbaum, J Hwang, T Sato, ... The oncologist 24 (9), e930-e942, 2019 | 46 | 2019 |
| Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: a Veterans' Affairs Central Cancer Registry (VACCR) database analysis WI Gonsalves, S Kanuri, T Tashi, I Aldoss, A Sama, I Al‐Howaidi, A Ganta, ... Journal of Surgical Oncology 104 (6), 667-671, 2011 | 38 | 2011 |
| A phase I/II study of the investigational drug alisertib in combination with abiraterone and prednisone (AP) for patients with metastatic castration-resistant prostate cancer … Jianqing Lin, Ashwin Reddy Sama, Jean H. Hoffman-Censits, Deborah Kilpatrick ... Journal of Clinical Oncology 32 (5s), 5107, 2014 | 33* | 2014 |
| Two randomized, placebo-controlled phase 3 studies of ruxolitinib (Rux)+ capecitabine (C) in patients (pts) with advanced/metastatic pancreatic cancer (mPC) after failure … H Hurwitz, E Van Cutsem, JC Bendell, M Hidalgo, CP Li, M Garrido, ... Journal of Clinical Oncology 35 (4_suppl), 343-343, 2017 | 24 | 2017 |
| Abstract CT124: A phase Ib/II study of BMS-813160, a CC chemokine receptor (CCR) 2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients (pts) with … D Le, ME Gutierrez, M Saleh, E Chen, AB Mallick, MJ Pishvaian, J Krauss, ... Cancer Research 78 (13_Supplement), CT124-CT124, 2018 | 21 | 2018 |
| Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A … SA Jacobs, JJ Lee, TJ George, JL Wade III, PJ Stella, D Wang, AR Sama, ... Clinical Cancer Research 27 (6), 1612-1622, 2021 | 18 | 2021 |
| Hepatoid carcinoma of the pancreas: a case report and review of the literature NL Williams, JD Palmer, V Bar-Ad, PR Anné, AR Sama, JC Weinstein, ... Case Reports in Pancreatic Cancer 1 (1), 3-6, 2015 | 12 | 2015 |
| Refractory fallopian tube carcinoma–current perspectives in pathogenesis and management AR Sama, RJ Schilder International Journal of Women's Health, 149-157, 2014 | 12 | 2014 |
| Clinical evaluation versus echocardiography in the assessment of rheumatic heart disease A Reddy, SK Jatana, MNG Nair Medical Journal Armed Forces India 60 (3), 255-258, 2004 | 12 | 2004 |
| Genomic and transcriptomic analyses related to the clinical efficacy of first-line nivolumab in advanced hepatocellular carcinoma from the phase 3 CheckMate 459 trial J Neely, J Yao, M Kudo, RS Finn, B Sangro, I Melero, A El-Khoueiry, ... Cancer Research 82 (12_Supplement), 2145-2145, 2022 | 10 | 2022 |
| Acceptance and commitment therapy with pancreatic cancer: an integrative model of palliative care—a case report CVF O'Hayer, KM O'Hayer, A Sama Journal of pancreatic cancer 4 (1), 1-3, 2018 | 10 | 2018 |
| A phase III, double-blind, randomized study of nivolumab (NIVO) and ipilimumab (IPI), nivo monotherapy or placebo plus transarterial chemoembolization (TACE) in patients with … B Sangro, JJ Harding, M Johnson, DH Palmer, J Edeline, GK Abou-Alfa, ... Journal of Clinical Oncology 39 (3_suppl), TPS349-TPS349, 2021 | 9 | 2021 |
| Gemcitabine and cisplatin plus ramucirumab or merestinib or placebo in first-line treatment for advanced or metastatic biliary tract cancer: A double-blind, randomized phase II … AR Sama, CS Denlinger, A Vogel, AR He, N Bousmans, W Zhang, ... Journal of Clinical Oncology 35 (4_suppl), TPS509-TPS509, 2017 | 8 | 2017 |
| Molecular profiling of synchronous colon cancers and anaplastic thyroid cancer in a patient with lynch syndrome JM Johnson, J Chen, SM Ali, IK Dardi, M Tuluc, D Cognetti, B Campling, ... Journal of Gastrointestinal Cancer 49, 203-206, 2018 | 7 | 2018 |
| HER-2-Positive ampullary adenocarcinoma: A case report K O'Hayer, J Farber, CJ Yeo, AR Sama Case Reports in Pancreatic Cancer 1 (1), 7-10, 2015 | 6 | 2015 |
| A case of periampullary adenocarcinoma in neurofibromatosis type 1 CA Kistler, JM Johnson, JM Winter, JP Baliff, AA Siddiqui, AR Sama Journal of Gastrointestinal Oncology 5 (6), E96, 2014 | 6 | 2014 |
| Preclinical antitumor activity of a CC chemokine receptor (CCR) 2/5 dual antagonist as monotherapy and in combination with immune checkpoint blockade Q Zhao, A Murtaza, A Bata, W Sun, CP Ho, R Vuppugalla, R Cherney, ... Cancer Research 78 (13_Supplement), 3760-3760, 2018 | 4 | 2018 |
